Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IMPDH2 | P12268 | 1/20 | 0.41 |
| ▸ | IMPDH1 | P20839 | 1/20 | 0.41 |
| ▸ | STS | P08842 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 6/20 | 0.38 |
| ▸ | CA1 | P00915 | 5/20 | 0.38 |
| ▸ | VCAM1 | P19320 | 2/20 | 0.37 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.37 |
| ▸ | CA3 | P07451 | 1/20 | 0.37 |
| ▸ | CA6 | P23280 | 1/20 | 0.37 |
| ▸ | CA9 | Q16790 | 1/20 | 0.37 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.37 |
| ▸ | NOS3 | P29474 | 1/20 | 0.36 |
| ▸ | NOS1 | P29475 | 1/20 | 0.36 |
| ▸ | NOS2 | P35228 | 1/20 | 0.36 |
| ▸ | RAD51 | Q06609 | 1/20 | 0.35 |
| ▸ | CASP3 | P42574 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | DRD2 | P14416 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3027684 | 0.83 | IMPDH2 (0.42) | IMPDH2IMPDH1STSCA2CA1 | |
| SCHEMBL818327 | 0.77 | IMPDH2 (0.45) | IMPDH2IMPDH1STSCA2CYP2A6 | |
| SCHEMBL30488974 | 0.77 | IMPDH2 (0.45) | IMPDH2IMPDH1STSCA2CYP2A6 | |
| SCHEMBL25418472 | 0.75 | STS (0.50) | IMPDH2IMPDH1STSCA2CA1 | |
| SCHEMBL7349772 | 0.74 | IMPDH2 (0.39) | IMPDH2IMPDH1STSCA2CA1 | |
| SCHEMBL17796275 | 0.74 | TRPV4 (0.38) | ALDH1A1 | |
| SCHEMBL9087127 | 0.74 | VCAM1 (0.48) | CA2CA1VCAM1TSHR | |
| SCHEMBL17796253 | 0.74 | CYP2A6 (0.46) | IMPDH2IMPDH1CA2CA1CYP2A6 | |
| SCHEMBL8731805 | 0.74 | KIF11 (0.39) | CA2CA1VCAM1CYP2A6ALDH1A1 | |
| SCHEMBL3031435 | 0.74 | ALDH1A1 (0.41) | CYP2A6ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113376962-B | Coloring composition and compound | 住友化学株式会社 | 2024-05-28 | — | — | CN | disclosed |
| CN-113376965-B | Coloring composition and compound | 住友化学株式会社 | 2024-05-28 | — | — | CN | disclosed |
| CN-113376963-B | Coloring composition and compound | 住友化学株式会社 | 2024-05-28 | — | — | CN | disclosed |
| CN-113376964-B | Coloring composition and compound | 住友化学株式会社 | 2024-04-26 | — | — | CN | disclosed |
| CN-113631661-B | Coloring composition, compound, color filter and display device | 住友化学株式会社 | 2023-11-07 | — | — | CN | disclosed |
| CN-113454167-B | Coloring composition, compound, color filter and display device | 住友化学株式会社 | 2023-08-15 | — | — | CN | disclosed |
| CN-107793407-B | Compounds useful as colorants | 住友化学株式会社 | 2022-07-08 | — | — | CN | disclosed |
| CN-107797382-B | Coloring composition | 住友化学株式会社 | 2022-02-22 | — | — | CN | disclosed |
| CN-107797381-B | Coloring composition and compound | 住友化学株式会社 | 2022-02-18 | — | — | CN | disclosed |
| CN-107024834-B | Compound and coloring composition | 住友化学株式会社 | 2021-11-23 | — | — | CN | disclosed |
| US-20100004438-A1 | DIARYLETHER DERIVATIVES AS ANTITUMOR AGENTS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2010-01-07 | — | — | US | disclosed |
| EP-2089373-A1 | STAT3/5 ACTIVATION INHIBITOR | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2009-08-19 | — | — | EP | disclosed |
| EP-1957073-A2 | MEDICINAL DRUG | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2008-08-20 | — | — | EP | disclosed |
| WO-2008044667-A1 | STAT3/5 ACTIVATION INHIBITOR | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2008-04-17 | — | — | WO | disclosed |
| US-20070270422-A1 | Aromatic Compounds | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2007-11-22 | — | — | US | disclosed |
| WO-2007066784-A2 | DIARYLETHER DERIVATIVES AS ANTITUMOR AGENTS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2007-06-14 | — | — | WO | disclosed |
| EP-1773797-A2 | AROMATIC COMPOUNDS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2007-04-18 | — | — | EP | disclosed |
| WO-2006014012-A2 | AROMATIC COMPOUNDS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2006-02-09 | — | — | WO | disclosed |
| US-5629406-A | AMINO ACID DERIVATIVES | SANKYO COMPANY, LIMITED (JP) | 1997-05-13 | — | — | US | disclosed |
| EP-0587311-A1 | Peptides capable of inhibiting the activity of HIV protease, their preparation and their therapeutic use | SANKYO COMPANY LIMITED (JP) | 1994-03-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100004438-A1 | DIARYLETHER DERIVATIVES AS ANTITUMOR AGENTS | ROS1, CBR1, CBR3 | IMPDH2 1699/4885IMPDH1 754/4885STS 2308/4885 |
| US-20070270422-A1 | Aromatic Compounds | COL1A1, COL2A1, COL14A1 | IMPDH2 4290/4885IMPDH1 3603/4885STS 2323/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.